The pharmaceutical industry in India was valued at US$ 33 billion in 2017 and generic drugs account for 20 percent of global exports in terms of volume, making the country the largest provider of generic medicines globally.
Mergers and acquisitions (M&As) are perpetual part of big pharmaceutical industries and we have witnessed many such mergers and acquisitions. The financial crisis and resulting uncertainty in the global economies has made it difficult for companies to predict future performance of their own or their target’s or to forecast synergies and other transaction benefits with the same level of confidence seen in the past. As a result, acquirors and targets have developed transaction structures that are aimed at bridging gaps in their respective assessments of valuation and risk.
This article is focusing on top Pharmaceutical M&As of the year 2019.
Antibiotic resistance (AMR) is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Antimicrobial Resistance is an increasingly serious threat to public health. The spread of multi-drug resistant bacteria and the lack of new antibiotics to treat infections caused by these organisms pose a rapidly increasing threat to human health which urgently needs to be tackled.
Development of new biopharmaceutical for different patient's need is now in some limited hand due to high R&D (Research and Development) cost and making therapy are not affordable for large segment of people in developing country.
United States half pharmacies are located within drug stores, grocery stores, hospitals, department stores, medical clinics, surgery clinics, universities, nursing homes, prisons, and other facilities. The remaining pharmacies are considered to be independent or privately owned. In USA, average salary of pharmacists is 99000-140000 USD per annum. It can be varied depending on many factors.
After completion of your bachelors or masters in pharmacy, you may have a question that how to make research career? How to get research experience because in industry most of them are asking about experience candidates? How to get good salary in R&D?
If you are getting direct research opportunities in industry then there was never been a difficulty but believe me this is not always a case.
Very soon we are going to see a huge gap for “right talent” in Indian pharma industry. In my view following could be the reasons and steps to be taken by industry:
a. At +2 level, boys are for engineering, girls are for medicine, and those who fail to get medical seats opt for pharmacy. Hence there is an increase in trend of girls graduating out of pharmacy colleges.
b. Most of Indians prefer their girl child to get married immediately after graduation or sometimes even when they are in their final years of course. (The latest demographic indicators provided by the health and family welfare ministry reveal that the national average age of marriage for girls was 20.6 years in 2008, up from 18.3 years in 2001. http://www.dnaindia.com/india/report-indian-women-push-back-marriage-age...)
c. After marriage probability of girl continuing higher studies or getting into job is reduced.
d. Most of recruiters have bias in considering girls as they are uncertain on when these girls leave the job for the reasons of marriage, re-location due to husband’s place of job or maternity.
Simply, Artificial intelligence (AI) means machine learning and behaving like humans which ultimately facilitates works of humans.
Whether you do aware or not but in the modern world, we are all surrounded by AI. There are many examples of AI which we are using (may be unknowingly) in our day to day life. For exm, social media, search engines, product recommendations, Email filters etc.
On the current pharmaceutical sector the generic drug have a significant value for its modern technology with accurate efficacy, easy available and cheaper price in drug delivery system. On the 20th century global pharmaceutical evaluation every country started to pull up their pharmaceutical sector on producing different kind of drugs with different dosage form to lead as a world pharmaceutical leader. That competition show a big positive sign for world health care sector.
Analysis of variance is abbreviated as ANOVA. ANOVA is developed by R.A. Fisher in 1920 for determination of variance between different groups. ANOVA is used for comparison of more than two population or population having more than two subgroups.
ANOVA is defined as the ratio of variability between the means and variability within the distribution.